Number of Articles: 8 | ||
1 | Development of thermostable Streptokinase by recombinant DNA technology as fibrinolytic agent for different thromboembolic disorders | |
Volume 1, Issue 2, July 2023, Page 34-45 | ||
Mohammed M Kassab | ||
2 | Results of two fibrinolytics in treatment of the early stage of empyema | |
Volume 29, Issue 1, January 2023, Page 120-126 | ||
amr el sayed tawfek; Mamdouh Elsharawy; Mohammad Ismail Ibrahim; Amr Hassan Mansour | ||
3 | Development of thermostable Streptokinase by recombinant DNA technology as fibrinolytic agent for different thromboembolic disorders | |
Volume 4, Issue 4, December 2022, Page 105-126 | ||
Kassab Mohammed L. | ||
4 | Intrapleural Streptokinase in Complicated Parapneumonic Effusions and Empyema | |
Volume 89, Issue 2, October 2022, Page 6268-6273 | ||
Haytham Mohamed Abd El Moaty; Khaled Mohammed Abdallah | ||
5 | Evolving Fibrinolytic Option in the Management of Second Stage of Empyema | |
Volume 28, Issue 5, September 2022, Page 1141-1146 | ||
Tamer Alawady; Mamdouh Elsharawy; Karim Elfakharany; Saad Rabie Samra; Ashraf Hamed Abdelsalam | ||
6 | Comparative Study between Medical Thoracoscope and Intrapleural Fibrinolytic Therapy in Complicated Parapneumonic Effusion and Empyema | |
Volume 76, Issue 5, July 2019, Page 4055-4061 | ||
Ibrahim Mohammed El-sayed Radwan; Eisa Ibrahim Afify; Ahmed Alsaeed Alsehrawey; Fawzi Mohamed Abd-Elfatah Omar | ||
7 | Role of Tenascin-C as a Predictor of Left Ventricular Remodeling after streptokinase in patients with acute Myocardial Infarction | |
Volume 30, Issue 3, July 2019, Page 89-95 | ||
Tarek M. Abdel-Rhman; Tamer T. Ismael; Hazem M. Ali; Hanna A. Saad | ||
8 | EFFECT OF LOW DOSE INTRACORONARY STREPTOKINASE ADMINSTIRATION IMMEDIATELY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ON LEFT VENTRICULAR FUNCTION AS ASSESSED BY SPECKLE TRAKING ECHOCARDIOGRAPHY | |
Volume 25, Issue 1, January 2019, Page 45-54 | ||
Ahmed Shafie Ammar; Mohammad Mustafa Al-Daydamony; Mohamed Ibrahim Amin; Ayman Mohamed Nagib | ||